Belarus, Republic of vs Sri Lanka: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Belarus, Republic of
16.0%
in 2025
Sri Lanka
0.0%
in 2025
Belarus, Republic of rank
163rd
Sri Lanka rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Belarus, Republic of
- Sri Lanka
How they compare
Belarus, Republic of currently reports 16.0% against 0.0% in Sri Lanka, a difference of 16.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Sri Lanka ahead.
Belarus, Republic of ranks 163rd and Sri Lanka ranks 165th of 192 countries.
Belarus, Republic of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus, Republic of | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 2.7% | 0.0% | 2.7% | Belarus, Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Belarus, Republic of or Sri Lanka?
- Belarus, Republic of, at 16.0% against 0.0% in Sri Lanka as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Belarus, Republic of and Sri Lanka?
- 16.0%, with Belarus, Republic of ahead.
- How many years of comparable data are there for Belarus, Republic of and Sri Lanka?
- 18 years are reported by both, from 2008 to 2025.
- How do Belarus, Republic of and Sri Lanka rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Belarus, Republic of ranks 163rd and Sri Lanka ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.